These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 21155893)
1. Ivermectin and milbemycin oxime in experimental adult heartworm (Dirofilaria immitis) infection of dogs. Snyder DE; Wiseman S; Cruthers LR; Slone RL J Vet Intern Med; 2011; 25(1):61-4. PubMed ID: 21155893 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the effectiveness of a combination product of spinosad and milbemycin oxime on the prophylaxis of canine heartworm infection. Snyder DE; Wiseman S; Bowman DD; McCall JW; Reinemeyer CR Vet Parasitol; 2011 Aug; 180(3-4):262-6. PubMed ID: 21530085 [TBL] [Abstract][Full Text] [Related]
3. ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months. McTier TL; Kryda K; Wachowski M; Mahabir S; Ramsey D; Rugg D; Mazaleski M; Therrien C; Adams E; Wolff T; Bowman DD Parasit Vectors; 2019 Jul; 12(1):369. PubMed ID: 31349867 [TBL] [Abstract][Full Text] [Related]
4. The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations. McCall JW Vet Parasitol; 2005 Oct; 133(2-3):197-206. PubMed ID: 16198822 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of ivermectin and milbemycin oxime efficacy against Dirofilaria immitis infections of three and four months' duration in dogs. McCall JW; McTier TL; Ryan WG; Gross SJ; Soll MD Am J Vet Res; 1996 Aug; 57(8):1189-92. PubMed ID: 8836373 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis. Blagburn BL; Arther RG; Dillon AR; Butler JM; Bowles JV; von Simson C; Zolynas R Parasit Vectors; 2016 Apr; 9():191. PubMed ID: 27044379 [TBL] [Abstract][Full Text] [Related]
7. Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs. Kryda K; Holzmer S; Everett WR; McCall JW; Mahabir SP; McTier TL; Maeder SJ Parasit Vectors; 2020 Jul; 13(1):339. PubMed ID: 32660542 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs. McTier TL; Six RH; Pullins A; Chapin S; McCall JW; Rugg D; Maeder SJ; Woods DJ Parasit Vectors; 2017 Nov; 10(Suppl 2):482. PubMed ID: 29143634 [TBL] [Abstract][Full Text] [Related]
10. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio Young LM; Wiseman S; Crawley E; Wallace K; Snyder DE Parasit Vectors; 2021 May; 14(1):284. PubMed ID: 34044864 [TBL] [Abstract][Full Text] [Related]
11. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs. Bowman DD; Grazette AR; Basel C; Wang Y; Hostetler JA Parasit Vectors; 2016 Jan; 9():12. PubMed ID: 26746229 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs. Cunningham CP; Brown JM; Jacobson GA; Brandon MR; Martinod SR Am J Vet Res; 2006 Sep; 67(9):1564-9. PubMed ID: 16948602 [TBL] [Abstract][Full Text] [Related]
13. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Kryda K; Six RH; Walsh KF; Holzmer SJ; Chapin S; Mahabir SP; Myers M; Inskeep T; Rugg J; Cundiff B; Pullins A; Ulrich M; McCall JW; McTier TL; Maeder SJ Parasit Vectors; 2019 Sep; 12(1):445. PubMed ID: 31506094 [TBL] [Abstract][Full Text] [Related]
14. Preventive efficacy of six monthly oral doses of Simparica Trio Myers JAE; Holzmer S; McCall JW; Mahabir SP; McTier TL; Maeder SJ; Kryda K Parasit Vectors; 2022 Mar; 15(1):81. PubMed ID: 35277191 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of ProHeart Bowman DD; McTier TL; Adams EL; Mahabir SP; Login JA; Bidgood T; Woods DJ Parasit Vectors; 2017 Nov; 10(Suppl 2):502. PubMed ID: 29143654 [TBL] [Abstract][Full Text] [Related]
17. Shifting the paradigm in Dirofilaria immitis prevention: blocking transmission from mosquitoes to dogs using repellents/insecticides and macrocyclic lactone prevention as part of a multimodal approach. McCall JW; Varloud M; Hodgkins E; Mansour A; DiCosty U; McCall S; Carmichael J; Carson B; Carter J Parasit Vectors; 2017 Nov; 10(Suppl 2):525. PubMed ID: 29143678 [TBL] [Abstract][Full Text] [Related]
18. Response of dogs treated with ivermectin or milbemycin starting at various intervals after Dirofilaria immitis infection. Rawlings CA; Bowman DD; Howerth EW; Stansfield DG; Legg W; Luempert LG Vet Ther; 2001; 2(3):193-207. PubMed ID: 19746662 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of a single dose of a novel topical combination product containing eprinomectin to prevent heartworm infection in cats. Baker CF; Tielemans E; Pollmeier MG; McCall JW; McCall SD; Irwin J; Chester ST; Carithers DS; Rosentel JK Vet Parasitol; 2014 Apr; 202(1-2):49-53. PubMed ID: 24703077 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Dirofilaria immitis. Blagburn BL; Dillon AR; Arther RG; Butler JM; Newton JC Vet Parasitol; 2011 Mar; 176(2-3):189-94. PubMed ID: 21295409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]